![Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer](https://pub.mdpi-res.com/cancers/cancers-13-03841/article_deploy/html/images/cancers-13-03841-ag.png?1628043076)
Cancers | Free Full-Text | Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer
![Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss - eBioMedicine Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss - eBioMedicine](https://www.thelancet.com/cms/attachment/c7dee2c1-05cf-401f-93cd-390cb1206598/gr1_lrg.jpg)
Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss - eBioMedicine
![Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research](https://www.ahajournals.org/cms/asset/aaeb2292-737e-43af-a29d-9c6d7556154d/circresaha.122.321116.fig09.jpg)
Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B | Circulation Research
![Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity | eLife Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity | eLife](https://iiif.elifesciences.org/lax/34961%2Felife-34961-fig9-v1.tif/full/1500,/0/default.jpg)
Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity | eLife
![Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/04bdee40-bc61-4d23-b36c-13cd8220d591/imm12936-fig-0001-m.jpg)
Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry - Freudenmann - 2018 - Immunology - Wiley Online Library
![Frontiers | HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers Frontiers | HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers](https://www.frontiersin.org/files/Articles/791535/fimmu-12-791535-HTML-r1/image_m/fimmu-12-791535-g001.jpg)